TSE:GUD
Knight Therapeutics (GUD.TO)
10.03
-0.06 (0.59%)
as of Sep 24, 2026, 2:38:21 pm Market Open.
135 watching
Financials 
Technical Analysis 0
TOP PICK
Only on the market a couple of months. There are only two people in the company. A drug has just been approved. Thinks it will be very exciting.
Michael SmedleyOwned
0
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Popular Articles
Most Recent Experts
The Weekly Buzzing Stocks by Billy Kawasaki
Stockchase
Joe Terranova
Virtus Investment Partners
Stephen Weiss, Founder, Short Hills Capital Partners
Short Hills Capital Partners
Rob Sechan, Managing Partner, New Edge Capital
New Edge Capital
Jason Snipe, CIO, Odyssey Capital Advisors
Odyssey Capital Advisors
Got hit today because they are issuing warrants. Good opportunity to buy in right now. Has a lot of cash. Very interesting fundamental story. Technically it looks very strong as well.